Home Cancer Leukemia

Leukemia

Latest
Leukemia

Conjoined Cells Form a Potent Immunotherapy Combo

acute myeloblastic leukemia (AML)
Leukemia

Broad Genomic Study of AML Provides Insight into Drug Responses

A research team from the Cancer Science Institute of Singapore has discovered that RUNX proteins play a part in the regulation of DNA repair. [National University of Singapore]
Leukemia

RUNX Proteins Found to be Integral to Efficient DNA Repair

Recent research uncovers a new approach for expanding blood-forming
Leukemia

Reversible Technique Developed for Stem Cell Expansion

Otsuka Pharmaceutical and its Astex Pharmaceuticals subsidiary have acknowledged that guadecitabine has failed a Phase III trial in a subgroup of patients with acute myeloid leukemia (AML; pictured). [Source: Peter Maslak via American Society of Hematology Image Bank]
Leukemia

Otsuka/Astex AML Candidate Guadecitabine Fails Phase III Trial

Leukemia Blood Cell [Kateryna Kon/Science Photo Library/Getty Images]
Leukemia

Leukemia Cells Take the Fast Track to the Nervous System

Leukemia

Soluble Antibodies Promote Tumor Progression by Inducing Immune Suppressive Cells

Leukemia

Pfizer Hands UCART19, Allogenic CAR-T Portfolio Rights to $300M Startup

Leukemia

Melanoma Spread May Be Averted with Repurposed Leukemia Drugs

Columbia biomedical engineers use soft fibers (red) to activate T cells (green)
Leukemia

Novel Biomaterials Boost T-Cell Production

Load more

Recently Featured

Stay Connected

557,677FansLike
45,821FollowersFollow
Copyright © 2019 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up